Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: The Diabetes in Germany (DIG) study

Cardiovascular Diabetology

Volumn 6, Issue , 2007, Pages

  Hanefeld, Markolf ^a   Koehler, Carsta ^a   Gallo, Silvina ^a   Benke, Inge ^a   Ott, Petra ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; GERMANY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PROGNOSIS; RISK; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; AGE; ATHEROSCLEROSIS; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; RISK FACTOR; SMOKING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 34249278785     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-6-13     Document Type: Article

References (17)

1. Alexander CM Landsman PB Teutsch SM Haffner SM Third National Health and Nutrition Examination Survey (NHANES III). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes 2003 52 1210-4 10.2337/diabetes.52.5.1210 12716754
2. Isomaa B Almgren P Tuomi T Forsen B Lahti K Nissen M Taskinen MR Groop L Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 2001 24 683-9 10.2337/diacare.24.4.683 11315831
3. Bonora E Targher G Formentini G Calcaterra F Lombardi S Marini F Zenari L Saggiani F Poli M Perbellini S Raffaelli A Gemma L Santi L Bonadonna RC Muggeo M The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study Diabet Med 2004 2 52-8 10.1046/j.1464-5491.2003.01068.x
4. Kylin E Studien ueber das Hypertonie-Hyperglykaemie-Hyperurikaemiesyndrom Zentralblatt fuer Innere Medizin 1923 44 105-127
5. Grundy SM Cleeman JI Daniels SR Donato KA Eckel RH Franklin BA Gordon DJ Krauss RM Savage PJ Smith SC Jr Spertus JA Costa F American Heart Association; National Heart, Lung, and Blood Institute Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement Ciculation 2005 112 2735-2752 10.1161/CIRCULATIONAHA.105.169404
6. Kahn R Buse J Ferrannini E Stern M American Diabetes Association; European Association for the Study of Diabetes The metabolic syndrome: time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 2005 28 2289-304 10.2337/diacare.28.9.2289 16123508
7. Gimeno Orna JA Lou Arnal LM Molinero Herguedas E Boned Julian B Portilla Cordoba DP Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes Rev Esp Cardiol 2004 57 507-13 10.1157/ 13062916 15225497
8. Costa LA Canani LH Lisboa HR Tres GS Gross JL Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes Diabet Med 2004 21 252-5 10.1111/j.1464-5491.2004.01124.x 15008835
9. Bruno G Merletti F Biggeri A Bargero G Ferrero S Runzo C Prina Cerai S Pagano G Cavallo-Perin P Casale Monferrato Study Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study Diabetes Care 2004 27 2689-94 10.2337/ diacare.27.11.2689 15505006
10. Marchesini G Forlani G Cerrelli F Manini R Natale S Baraldi L Ermini G Savorani G Zocchi D Melchionda N WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes Diabet Med 2004 21 383-7 10.1111/j.1464-5491.2004.01115.x 15049944
11. Ilanne-Parikka P Eriksson JG Lindstrom J Hamalainen H Keinanen-Kiukaanniemi S Laakso M Louheranta A Mannelin M Rastas M Salminen V Aunola S Sundvall J Valle T Lahtela J Uusitupa M Tuomilehto J Finnish Diabetes Prevention Study Group Prevalence of the metabolic syndrome and its components: Findings from a Finnish general population sample and the Diabetes Prevention Study cohort Diabetes Care 2004 27 2135-40 10.2337/diacare.27.9.2135 15333474
12. Kompoti M Mariolis A Alevizos A Kyrazis I Protopsaltis I Dimou E Letzas I Levisianou D Gova A Melidonis A Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes Cardiovascular Diabetology 2006 5 21 1618385 17020601 10.1186/1475-2840-5-21
13. Taskinen MR Kuusi T Helve E Nikkila EA Yki-Jarvinen H Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes Arteriosclerosis 1988 l8 168-177
14. Saely CH Koch L Schmid F Marte T Aczel S Langer P Hoefle G Drexel H Adult Treatment Panel III but not International Diabetes Federation 2005 criteria predict clinical cardiovascular events in subjects who underwent coronary angiography Diabetes Care 2006 29 901-907 10.2337/ diacare.29.04.06.dc05-2011 16567835
15. Guzder RN Gatling W Mullee MA Byrne CD Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes Diabetologia 2006 49 49-55 10.1007/s00125-005-0063-9 16341841
16. Hillier TA Rizzo JH Pedula KL Cauley JA Schwartz AV Ensrud KE Browner WS Increased mortality associated with the metabolic syndrome in older women with diabetes Diabetes Care 2005 28 2258-60 10.2337/ diacare.28.9.2258 16123504
17. Hanefeld M Leonhardt W Das metabolische Syndrom Dt Gesundh-Wesen 1981 36 545-551